Publications by authors named "C Rocha-de-Souza"

Objectives: Infections due to carbapenemase-producing Enterobacterales harboring more than one carbapenemase-encoding gene spreads mainly by plasmid and transposon mobilization.

Objectives: Analyze the mobile genetic elements carrying bla and bla of K. pneumoniae carbapenemase co-producers (KpKN).

View Article and Find Full Text PDF

Pseudomonas aeruginosa, an opportunistic pathogen often found in Healthcare-associated infections (HAI), has shown increased resistance to carbapenems (imipenem, meropenem, doripenem), the primary treatment options. We've seen a rise in carbapenemase-producing P. aeruginosa in Brazil, including NDM-producers.

View Article and Find Full Text PDF
Article Synopsis
  • Enterobacter cloacae complex is a significant multidrug-resistant pathogen found in hospitals, prompting a study on its antimicrobial resistance and genetic factors in Brazil.
  • The study screened 94 clinical isolates, finding 20.2% (19 isolates) resistant to colistin, with high levels of resistance indicated by MIC values ranging from 4 to 128 µg/mL.
  • Genetic analysis revealed several carbapenemase and polymyxin resistance genes, along with diverse genetic profiles among the isolates, but no predominant clone was established.
View Article and Find Full Text PDF

Introduction: contributes significantly to the global issue of multidrug-resistant (MDR) nosocomial infections. Often, these strains demonstrate resistance to carbapenems (MDR-CRAB), the first-line treatment for infections instigated by MDR . Our study focused on the antimicrobial susceptibility and genomic sequences related to plasmids from 12 clinical isolates of that carry both the blaOXA-58 and carbapenemase genes.

View Article and Find Full Text PDF
Article Synopsis
  • Carbapenemase production is a significant global health concern, and analyzing antimicrobial resistance (AMR) data is essential for effective public health policies, as showcased in this study focused on Brazil's AMR Surveillance Network.
  • The study evaluated carbapenemase detection rates in Brazilian hospitals from 2015 to 2022, finding trends such as a notable increase in blaNDM detection and a decrease in blaKPC for Enterobacterales, particularly after the onset of the COVID-19 pandemic.
  • Overall, the findings highlight the resilience of the AMR Surveillance Network and indicate a concerning shift in carbapenemase profiles, with blaNDM becoming increasingly prevalent.
View Article and Find Full Text PDF